Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pulmonary > Restrictive/Inflammatory Lung Disease > Flashcards

Restrictive/Inflammatory Lung Disease Flashcards

1
Q

How is restrictive physiology defined? (PFT values)

A

Total Lung Capacity less than 80% predicted.

Functional Residual Capacity (Thoracic Gas Volume) less than 80% predicted.

Symmetrically reduced FEV1 and FVC (ratio still the same)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Restrictive physiology may be caused by ______ in lung elastic recoil or disease in the ______ or _____.

A

Increase, chest wall, pleura

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the relaxation pressure?

A

Relaxation pressure is the measure of the total compliance of a system. This takes the compliance of the chest wall as well as the compliance of the lung into account.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

True or False: The pressure-volume curves that we typically look at are only depicting the lung compliance, not chest complaince.

A

True! This is why changes in the chest wall compliance do not affect the slope of the curve, they only shift the whole thing up or down.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is elasticity?

A

Elasticity is the tendency of a structure to return to its initial form after deformation (e.g. springs with high elastic recoil (elastance) has stronger tendency to return to its resting state when stretched)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Compliance is the inverse of _____

A

elastance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Generally, ______ diseases make it hard to exhale and _______ diseases make it hard to inhale

A

obstructive, restrictive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Inflammation or scarring may expand the _____ and reduce _____

A

interstitium, compliance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does pulmonary edema increase elastic recoil/decrease compliance?

A

Pulmonary edema can increase the mass of the interstitium making it thicker and stiff. It can also deplete surfactant and increase mass and stiffness of the parenchyma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How can surfactant depletion increase elastic recoil/decrease compliance?

A

Surfactant depletion increases alveolar surface tension which leads to alveolar collapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

All alveolar filling processes increase _______ and decrease ____

A

elastance, compliance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pleural effusion, Asbestos-related pleural plaque, and Kyphoscoliosis all ____ the overall _____ by decreasing ____ of the _____

A

decrease, compliance, compliance, chest wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can you determine between restrictive lung disease and restrictive physiology?

A

In restrictive lung disease, the slope of the P-V curve is reduced. In restrictive physiology, the slope of the P-V curve is preserved but the whole curve is shifted downloards.

DLCO/VA is reduced in restrictive disease but preserved in restrictive physiology.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

True or False: Restrictive chest wall diseases generally do not cause gas exchange problems.

A

True. Restrictive chest wall (restrictive physiology) generally doesn’t cause gas exchange problems unless very severe.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is gas exchange impaired in restrictive lung disease?

A

There is a loss of alveolar surface area due to decreased lung volumes and decreased alveolar volumes. Also, the thickening of the alveolar walls limits diffusion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DLCO is corrected for _______ using helium dilution technique

A

alveolar volume (VA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When there is restrictive physiology, DLCO will _____

A

decrease in proportion to volume but DLCO/VA (DLCO corrected for VA) is normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

When there is restrictive lung disease present, there is a reduction in _____

A

DLCO AND DLCO/VA

Note that with restrictive lung disease, DLCO is decreased and is still decreased even after correcting for alveolar volume (except for in patients with early stage pulmonary fibrosis). With restrictive physiology, the correction of alveolar volume will make the value normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Name 4 acute restrictive processes

A
  1. Pulmonary edema
  2. ARDS/DAD
  3. Pneumonia
  4. Pleural effusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Name 3 chronic restrictive processes

A
  1. Interstitial lung disease
  2. Pleural fibrosis/plaques
  3. Pleural effusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Restrictive processes can be acute or chronic. What is more common?

A

Chronic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

If a patient has reduced lung voluems AND reduced FEV1/FVC, do they have obstructive or restrictive disease?

A

They have a mix of obstructive and restrictive disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Give 4 common examples of mixed obstructive disease

A
  1. coal miner (interstitial disease from occupation) who smokes (emphysema)
  2. obese person (chest wall restriction) with poorly controlled asthma (obstructive)
  3. combined pulmonary fibrosis and emphysema
  4. fibrotic hypersensitivity pneumonitis (causes mixed)
  5. sarcoidosis (causes mixed)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is interstitial lung disease?

A

ILD is a heterogeneous group of disorders characterized by a combination of inflammation or scarring.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Pulmonary fibrosis is characterized by ___

A

scarring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How do patients with interstitial lung disease typically present? (5)

A
  1. Dyspnea with exertion
  2. Cough
  3. Subacute to insidious timing
  4. Restrictive PFTs with decreased DLCO
  5. Abnormal lung imaging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

There are many kinds of interstitial lung disease (hundreds). Why is specific diagnosis for interstitial lung disease important?

A

It is important to be specific with diagnosis because prognosis varies a lot between different types of ILD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

how do you diagnose interstitial lung disease? (3 steps)

A

Clinical, radiographic, pathologic.

  1. The clinical context has to do with associated diseases, exposures, occupation, drugs, lab testing.
  2. High resolution CT (to look for pattern of damage)
  3. Pathologic pattern on surgical lung biopsy

You need all 3 of these. Etiology alone is insufficient because diseases can manifest in many different injury patterns. Pathology patterns alone are insufficient too because pattern of involvment can be a result of many different diseases. You need to combine all 3 strategies to narrow down the diagnosis.

29
Q

What 3 things do you look for in physical exam for ILD?

A

Auscultation: end-inspiratory velcro-like crackles

Digital clubbing in advanced cases of ILD

Joint and skin exam is important in identifying coexistent (causitive?) collagen vascular disease

30
Q

What are the treatment options for ILD?

A
  1. Remove offending exposure if possible (at home, at work, etc)
  2. Immunosuppressive therapy (depends on type and etiology). In many of the ILD cases, the patients’ immune system is attacking the lungs so immunosuppression can help.
  3. Idiopathic pulmonary fibrosis is non-inflammatory so they need to be treated by nintedanib and pirfenidone to slow the fibrosis.
  4. Oxygen
  5. Transplant
31
Q

What is idiopathic pulmonary fibrosis?

A

Idiopathic pulmonary fibrosis is a scarring lung disease with a pattern of injury of usual interstitial pneumonia (UIP).

32
Q

True or False: Idiopathic pulmonary fibrosis is a disease of younger patients

A

False! IPF is a disease that occurs in older patients (typically 60 and older)

33
Q

True or False: Idiopathic pulmonary fibrosis is not associated with tobacco use.

A

FALSE! IPF is associated w/ tobacco use

34
Q

What is the median survival from diagnosis of idiopathic pulmonary fibrosis?

A

2-3 years

35
Q

What does idiopathic pulmonary fibrosis look like with HRCT?

A

There is peripheral and basical predominant reticulation. This is the web/lined appearance at the periphery of the lungs. In normal lungs, the last cm or two of the periphery should be clear as the airways become microscopic but with IPF there are pronounced lines. There is also traction bronchiectasis (airways being pulled open by the surrounding lung parenchyma).

36
Q

What does idiopathic pulmonary fibrosis look like in histology?

A

Spatially and temporally heterogenous fibrosis with fibroblast foci, juxtaposition of fibrotic and normal lung.

37
Q

What are 2 medications that can slow down the fibrosis in idiopathic pulmonary fibrosis?

A

Pirfenidone, nintedanib

38
Q

What is nonspecific interstitial pneumonia (NSIP)?

A

It is an interstitial disease that presents similarly to other interstitial lung diseases. It may be idiopathic, collagen vascular disease related (RA, Sjogren’s, scleroderma, myositis), fibrotic HP, or drug-related.

39
Q

Nonspecific interstitial pneumonia happens most often affects what age and gender?

A

younger females

40
Q

Is prognosis better for idiopathic pulmonary fibrosis or nonspecific interstitial pneumonia?

A

Prognosis is better for nonspecific interstitial pneumonia

41
Q

True or False: Nonspecific interstitial pneumonia does not respond to anti-inflammatory therapy.

A

False. Nonspecific interstitial pneumonia responds to anti-inflammatory therapy

42
Q

How does nonspecific interstitial pneumonia look in HRCT?

A

Basilar predominant reticular abnormality with volume loss, traction bronchiectasis, and frequently presenting with ground glass opacity. Rarely, there is honeycombing

43
Q

What are the histological findings for nonspecific interstitial pneumonia?

A

Temporally homogeneous fibrosis with varying degrees of inflammation and fibrosis.

44
Q

Respiratory bronchiolitis interstitial lung disease, desquamative interstitial pneumonia, and pulmonary langerhans cells histiocytosis are 3 diseases categorized under _____

A

Smoking-related ILD

45
Q
  • young smoker
  • imaging: cysts and nodules
  • upper lobe predominant
  • mixed PFTs
  • PTX common
  • 15% extrapulm disease–including bone lesions, pituitary involvement
  • treatment is smoking cessation

What is the disease?

A

Pulmonary langerhans cell histiocytosis (PLCH) (a type of smoking-related ILD)

46
Q

What is pneumonia?

A

Inflammation in the alveoli. It can be either infectious or noninfectious (most comonly it’s infectious)

47
Q

What is idiopathic organizing pneumonia called?

A

cryptogenic organizing pneumonia

48
Q

What can cause organizing pneumonia?

A

It can be idiopathic, or secondary to an underlying disease, drugs, or exposures.

49
Q

What does organizing pneumonia look like under HRCT?

A

Ground glass and consolidation that can migrate over time.

50
Q

What is typical treatment for organizing pneumonia?

A

Very responsive to steroids, but it can take 6-12 months of treatment. Relapse is possible with steroid withdrawal

51
Q

What is eosinophilic pneumonia?

A

Eosinophils filling alveolar spaces

52
Q

Is eosinophilic pneumonia infectious or non-infectious?

A

Non-infectious

53
Q

How does eosinophilic pneumonia present? What does it mimic?

A

It mimics ARDS and presents with acute respiratory failure

54
Q

How is eosinophilic pneumonia diagnosed?

A

It is diagnosed by sampling the fluid in the alveolar spaces to see if there are eosinophils

55
Q

How is eosinophilic pneumonia treated?

A

They resolve with steroids

56
Q

Is eosinophilic pneumonia acute or chronic?

A

It can be either. Chronic eosinophilic pneumonia is subacute onset with associated asthma while acute mimics ARDS and presents with acute respiratory failure.

57
Q

With eosinophilic pneumonia, is there an increased eosinophil count in blood?

A

There is an increased eosinophil count in blood in chronic eosinophilic pneumonia

58
Q

What is lymphangioleiomyomatosis?

A

A mutation in tuberous sclerosis gene 1 or 2 causes this cystic lung disease that occurs exclusively in young women. There is peribronchovascular proliferation of smooth muscle cells. These basically block off distal airways and produce cysts and nodules. There is obstructive pattern on PFTs and spontaneous pneumothorax and chylothorax are common (remember that anything with cysts increase chance of pneumothorax). This disease sometimes produces renal tumors as well.

This disease is potentially treated with mTOR inhibitors (sirolimus)

59
Q

What is a granuloma?

A

A collection of inflammatory cells that forms a ball that gets surrounded by cells that start to look like epithelial cells. This is an immune reaction.

60
Q

What is sarcoidosis?

A

It is a systemic granulomatous disorder of unknown etiology. It commonly affects lungs, eyes, and skin

61
Q

True or False: Sarcoidosis doesn’t typically appear on CXRs

A

False. Sarcoidosis causes abnormal CXR in up to 90% of sarcoidosis cases

62
Q

True or False: Lympadenopathy is common for sarcoidosis patients

A

True

63
Q

True or False: Sarcoidosis may present as a mix of obstructive and restrictive processes

A

True. There is airway involvement in up to half of sarcoidosis cases and there may be restrictive, obstructive, or mixed PFTs in sarcoidosis.

64
Q

How do sarcoidosis patients present?

A

Cough, chest pain, and sometimes wheezing

65
Q

Does sarcoidosis typically appear before 40 y/o or after?

A

Before 40 y/o

66
Q

What’s going on here?

A

This CXR has bulky lymph nodes (hilar and paratracheal). This is a hallmark of sarcoidosis.

67
Q

What’s going on here?

A

This is a form of sarcoidosis that shows a net-like pattern affecting the upper lobes. The scarring in the upper lobes is pulling up the airways (you can see the main bronchi bending upwards).

68
Q

How do you diagnose sarcoidosis?

A

You need to find granulomas that are idiopathic by excluding other causes of granulomas, there needs to be the clinical findings of cough, chest pain, or wheezing.

69
Q

How do you treat sarcoidosis?

A

Sarcoidosis typically resolves on its own but if there is progressive organ injury, you need to treat with immunosuppression (steroids or cytotoxic drugs)

Pulmonary (39 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions